Ignite Creation Date:
2025-12-25 @ 12:34 AM
Ignite Modification Date:
2026-05-07 @ 11:47 AM
Study NCT ID:
NCT04415567
Status:
COMPLETED
Last Update Posted:
2020-06-04
First Post:
2020-05-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation
Sponsor:
Jinyang Gu
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
XH-20-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None